C
Camp4 Therapeutics Corporation (CAMP)
NGM – Real Time Price. Currency in USD
4.50
+0.10 (2.27%)
At close: May 12, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NGM – Real Time Price. Currency in USD
4.50
+0.10 (2.27%)
At close: May 12, 2026, 4:00 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 7.35 | 6.05 | 10 | |
| Quick ratio | 7.35 | 5.63 | 10 | |
| Debt to Equity | 0.04 | 0.30 | 9.0 | |
| Debt to Assets | 0.02 | 1.04 | 9.0 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 7.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | 350K | 652K | 3M | 3M |
| Gross Profit | -947K | -1M | -1M | 2M | 2M |
| Operating Income | -45M | -52M | -53M | -52M | -52M |
| Net Income | -44M | -49M | -52M | -80M | -80M |
| EBITDA | -44M | -50M | -51M | -50M | -50M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | -8.03 | 66.45 | 5.5 |
| Next quarter | 58.09 | 69.45 | 10 |
| Current year | 45.34 | 70.84 | 10 |
| Next year | 38.97 | 8.42 | 8.0 |
| Weighted average score | 8.4 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -56.22 | -166.79 | -56.35 | 156.1 | 3.3 |
| Y/Y | -46.62 | -203.36 | -11.68 | 140.52 | 3.3 |
| 3y average | 507.26 | -23.93 | N/A | 7.84 | 4.5 |
| 5y average | N/A | N/A | N/A | N/A | 1.0 |
| Weighted average score | 3.0 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Company's cash reserves $110.9M significantly exceed its total debt $2.0M, ensuring strong financial flexibility
Total current assets $114.1M exceed Total current liabilities $15.5M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
The company generates positive free cash flow $6.3M, supporting its financial health